$VCEL

Flynn Sean C. sold $603K of VCEL

Flynn Sean C. (Chief Legal Officer) sold 15,000 shares of Vericel Corp (VCEL) at $40.21 ($0.60M total) on 2026-06-18 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Flynn Sean C.
Published Jun 22, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 22, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VCEL
Neutral
high confidence
Mentioned
$VCEL
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VCELNeutralLow
01

Why it matters

The disclosure provides a concrete datapoint on insider activity but does not include new company fundamentals (no guidance, trial results, deals, or regulatory actions).

02

Market read

Traders may note insider selling, but the pre-arranged 10b5-1 structure and lack of fundamental updates make it low-conviction for price action.

03

What to watch

The filing does not state tax, diversification, or personal liquidity needs; without context, the sale size alone is not a strong directional signal.

Relevance 4/10Novelty 4/10Timing: Filed 2026-06-22; transaction dated 2026-06-18.

Background

This is an SEC Form 4 insider transaction for Vericel Corp (VCEL) by its Chief Legal Officer.

Company-level read

Ticker impact

$VCELNeutralHigh confidence
Context

Vericel’s Chief Legal Officer, Sean C. Flynn, sold 15,000 shares at $40.2100 under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect would be sentiment-only and small.

Evidence & confidence

Form 4 is a primary filing, but the transaction is an open-market sale under a 10b5-1 plan with no accompanying operational/regulatory catalyst.

Market effects

Minimal—no sector-wide regulatory/clinical/financing signal is disclosed.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still coincide with internal expectations of near-term risk; monitor for clustering of sales.

Key entities

  • Vericel Corp

    Subject of the Form 4 insider sale disclosure.

  • Sean C. Flynn

    Chief Legal Officer who sold 15,000 shares under a 10b5-1 plan.

Related articles

$VCELMedAI 8/10

Vericel Q2 Earnings Call Highlights

Vericel (NASDAQ: VCEL) reported Q2 earnings call updates. Burn Care revenue rose 22% to about $12M, with Epicel at $10.4M and NexoBrid above $1.5M. 2026 guidance was raised to $330M-$340M total revenue, MACI to $284M-$290M, Burn Care to $46M-$50M, and Q3 revenue to $76.5M-$78.5M. Board authorized a $200M buyback.

$VCELHigh

Vericel Corp (VCEL): Results of Operations and Financial Condition

Vericel Corp (VCEL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991earningsreleaseq22026.htm EX-99.1 Document Exhibit 99.1 Vericel Corporation 25 Blue Sky Drive Burlington, MA 01803 T 617 588-5555 F 617 588-5554 www.vcel.com Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Sh